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Incomplete Kawasaki disease represents a diagnostic challenge for pediatricians. In the absence of classical
presentation, the laboratoristic evaluation of systemic inflammation can help in placing the correct diagnosis to
promptly start adequate therapy. Erythema multiforme is an acute, self-limiting condition considered to be a
hypersensitivity reaction commonly associated with various infections or medications. This aspecific skin condition
has been rarely described as a sign of Kawasaki disease. We report on the case of a 4 years old boy presenting
high-grade fever associated with erythema multiforme and evidence of systemic inflammation who showed a good
response to prompt treatment with intravenous immunoglobulins.
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Kawasaki disease is an acute, self-limited vasculitis of un-
known etiology with a predilection for the involvement of
coronary arteries, that affects predominantly infants and
young children [1,2]. The diagnosis is based on the pres-
ence of fever associated with other transient typical signs,
that rarely are simultaneously present at the time of first
observation, but can appear subsequently. Indeed, there is
no single pathognomonic clinical or laboratoristic finding
for certain diagnosis. However, early recognition of Kawa-
saki disease is important to promptly start adequate ther-
apy with intravenous immunoglobulins to prevent the
development of coronary aneurysms [1,3-5]. Diagnosis of
incomplete Kawasaki disease is even more difficult for
pediatricians, because in the absence of classical presenta-
tion, vasculitis could be misdiagnosed and recognized late
[6]; moreover, the incomplete form is at risk of heart com-
plications, too [1,7]. Cutaneous manifestations are one of
the diagnostic criteria in Kawasaki disease, but they are
variable and non specific. Even if the typical findings of
cutaneous changes are multiple symmetrical erythematous
eruptions on the extensor surfaces of the extremities
developing after 3–5 days of fever [1,8], Kawasaki disease
may rarely present as erythema multiforme [9,10]. We* Correspondence: vieruf@hotmail.it
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multiforme as presenting sign of incomplete Kawasaki
disease.Case presentation
A 4 years old boy was admitted to our Hospital for a one
day history of remittent fever (up to 40.0C), accompanied
by irritability and annular, slightly itchy rash, started on
his hands and feet and progressively extended to the flexor
and extensor surfaces of the extremities, with relative
sparing of the trunk (Figure 1). The child appeared ex-
tremely suffering. Physical examination showed bilateral
lymphadenopathy (< 1.5 cm diameter) and hyperemic
pharynx without exudate. The child did not report ab-
dominal pain or arthralgia. Initial laboratoristic evaluation
showed marked lymphocitosys with neutrophylia, hypona-
tremia and evidence of systemic inflammation (Table 1).
As throat swab resulted positive for streptococcus pyo-
genes, parenteral administration of ceftriaxone was
started. Infectious profile: blood and urine cultures,
polymerase chain reaction for adenovirus, parvovirus
B19, citomegalovirus, Epstein-Barr, virus herpes 6 virus,
serology for herpes simplex virus, echovirus, coxsackie
virus, mycoplasma pneumoniae were negative. Anti-
nuclear antibody titer was negative. Abdomen ultrasound
showed the absence of hepatosplenomegaly or hydrops of
the gallbladder. Despite starting antibiotic therapy, the
child persisted with remittent fever and irritability.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Child’s cutaneous manifestations at hospital admission (2nd day of fever). Lesions started acutely as numerous sharply
demarcated red or pink macules that then became papular. Annular lesions were appreciable symmetrically on the distal extremities (A and B),
involving also palms (C) and soles.
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target-like erythematous lesions compatible with ery-
thema multiforme (Figure 2A and B). Blood test per-
formed in 4th day of fever confirmed the picture of
systemic inflammation (Table 1). In 6th day of fever the
child showed mild bilateral bulbar conjunctivalTable 1 Laboratoristic evaluation during hospitalization and
Investigation 2nd day admission 4th day 6th
White blood cell count mm3 18 400 17 140 1
Red blood cell count mm3 5 010 000 4 550 000 3
Hemoglobin g/dl 13.6 12.5
Platelets mm3 262 000 211 000 2
Neutrophils % 88.5 89.5
ESR mm/h 62
CRP mg/dl 9.21 17.36
Procalcitonin ng/ml 3.31 6.74
Albumin g/dl 3.4
Sodium mEq/l 131 134
Potassium mEq/l 4.52 3.47
AST U/l 29 65
ALT U/l 15 20
GGT U/l 13 13
Fibrinogen mg/dl 425 560
Ferritin ng/ml
Antistreptolysin O titer U/ml
Urine white blood cells mm3 8
IVIg: intravenous immunoglobulins.
ESR: erythrocyte sedimentation rate.
CRP: C-reactive protein.
AST: aspartate aminotransferase.
ALT: alanine aminotransferasi.
GGT: gamma-glutamyl transpeptidase.injection without exudate. Elevated antistreptolysin O
antibody titer confirmed recent streptococcus pyo-
genes infection. Electrocardiogram revealed abnormal-
ities in ventricular repolarization (T-waves negative in
V6), but echocardiography did not show coronary
alterations.follow-up
day IVIg 8th day 10th day 12th day discharge 26th day
0 210 3 960 4 590 4 410 4 350
760 000 4 390 000 4 200 000 4 410 000 4 330 000
10.2 12.1 11.4 11.9 12.1
31 000 380 000 498 000 543 000 210 000
79.4 43.7 28.7 43.1 29.4
64 85 78 19
12.94 4.88 2.11 0.89 0.02
0.71 0.31 0.05
3.0
133 132 137
2.77 4.48
46 39
18 19 19
9 11 13
399
3 460
126 2 0
Figure 2 Changes in child’s skin manifestations during hospitalization. Annular lesions gradually enlarged into the characteristic “target”
lesions with a regular round shape and three concentric zones: a central darker red area, a paler pink zone and a peripheral red ring. Figure
shows skin lesions on 4th day (A), 5th day (B) of fever and the day after (7th day) the administration of intravenous immunoglobulins (C).
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the basis of the presence of fever persisting at least 5 days,
associated to 2 classic diagnostic criteria (polymorphous
exanthem and aseptic conjunctival injection), increased levels
of ESR and CRP with 4 supplemental laboratory criteria
(hypoalbuminemia, anemia, leucocytosis and leucocyturia).
Treatment with intravenous immunoglobulins (2 gr/Kg)
and high-dose aspirin was promptly started. After immu-
noglobulins administration the child's clinical conditions
improved with defervescence and reduction in systemic
inflammation indexes. After 24 hours the child presented
again transient fever up to 39.5C, that responded to para-
cetamol with final defervescence. Cutaneous lesions pro-
gressively faded (Figure 2C). Aspirin dose was reduced to
low-dose (5 mg/Kg per day), after the child has been
afebrile for 48 hours. As expected, on 10th day blood ana-
lysis showed thrombocytosis. On 12th day from the onset
of the fever electrocardiogram and cardiac ultrasound
were normal, so the child was discharged. Two weeks after
the discharge erythema multiforme was completely
resolved, no desquamation was observed and flogosis in-
dexes returned into normal range. Low-dose aspirin was
maintained until patient shows no evidence of coronary
changes by 8 weeks after the onset of illness. Cardiologic
follow-up in the next 6 months was normal.
Discussion
Kawasaki disease is the most common systemic vascu-
litis in childhood after Henoch-Schonlein purpura andthe most common cause of acquired heart disease
among children living in West countries [11]. Since its
identification in 1967 [12], it is now accepted that Kawa-
saki disease can be considered as a continuous spectrum,
ranging from incomplete to complete forms, that include
all diagnostic criteria [13]. Diagnostic criteria of Kawa-
saki disease postulated by the American Heart Associ-
ation are fever persisting at least 5 days in presence of at
least 4 principal features such as changes in extremities
(acute erythema of palms/soles or edema of hands/feet;
subacute periungual peeling of fingers/toes), polymorph-
ous exanthem, bilateral bulbar conjunctival injection
without exudate, changes in lips and oral cavity (ery-
thema, lips cracking, strawberry tongue, diffuse injection
of oral and pharyngeal mucosa), cervical lymphadenop-
athy (> 1.5 cm diameter), usually unilateral [1]. All these
signs are non specific and frequently overlap with other
diseases, particularly with systemic juvenile idiopathic
arthritis [1]. In our case, this condition was excluded for
the absence of typical clinical features such as arthritis,
intermittent fever, evanescent erythematosus rash, hepa-
tosplenomegaly or serositis. The prevalence of incom-
plete Kawasaki disease is 15-36% [6]. A recent report of
a series of 955 patients showed that the cases presenting
the incomplete form represented the 23% of the whole
cohort; patients with incomplete Kawasaki disease had a 1
day longer median interval from onset to diagnosis and
were less likely to be treated with intravenous immunoglo-
bulins (86% versus 96%). However, overlapping laboratory
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the two forms can be considered as two sides of the same
coin [7]. Incomplete Kawasaki disease should be consid-
ered in all children with unexplained fever for ≥ 5 days
associated with 2 or 3 of the principal clinical features of
Kawasaki disease, according to the algorithm proposed by
American Heart Association [1]. Laboratory findings can
help in diagnosis if systemic inflammation (ESR ≥ 40 mm/
hr and CRP ≥ 3.0 mg/dL) is associated to other supple-
mental laboratory criteria such as hypoalbuminemia (albu-
min < 3.0 g/dL), anemia for age, elevation of alanine
aminotransferase, trombocythosis (platelets after 7 days >
450 000/mm3), leucocytosis (white blood cell count >
15 000/mm3) and sterile leucocyturia (urine > 10 white
blood cells/high-power field). In presence of at least 3 sup-
plemental criteria, as in our case, treatment with intraven-
ous immunoglobulins and cardiac ultrasound have to be
performed [1].
The case we reported is particularly interesting for the
unusual presentation of incomplete Kawasaki disease.
Indeed, erythema multiforme was reported as a cutane-
ous manifestation of classic Kawasaki disease in only 2
young children, a 22-month-old girl in 1979 [9] and a
16-month-old boy in 2010 [10]. In addition, other 3
patients were described affected by Kawasaki disease
associated to annular lesions [14]. To our knowledge,
this is the first report of erythema multiforme as first
sign of incomplete Kawasaki disease.
The skin eruption of Kawasaki disease has been
described as an erythematous rash usually appearing
within 5 days of the onset of fever. The most common is a
non specific, diffuse maculopapular eruption. Occasionally
some other skin pictures such as urticarial exanthem, scar-
latiniform rash, erythroderma, erythema-multiforme-like
rash or, rarely, fine micropustular eruption have been
described. The rash usually is extensive, with involvement
of the trunk and extremities and accentuation in the peri-
neal region, where early desquamation may occur [1]. In
our case the rash erupted the first day of fever as annular,
slightly itchy cutaneous manifestations that evolved to
multiple target-like erythematous lesions compatible with
erythema multiforme in 4th day of fever. Erythema multi-
forme was more appreciable at the extremities, including
palms and soles, with relative unusual sparing of the
trunk. We did not observed changes in the extremities,
neither changes of the lips and oral cavity.
Erythema multiforme is an acute, self-limited, sometimes
recurring, skin condition considered to be a hypersensitiv-
ity reaction associated with certain infections, particularly
herpes simplex virus and mycoplasma pneumoniae, and
with medications such as penicillins and non steroidal
anti-inflammatory drugs, commonly used in children [15].
It usually occurs in adults 20 to 40 years of age, although it
can occur in children [15,16]. Erythema multiforme usuallyhas mild or no prodromal symptoms, and patients may ex-
perience itching and burning at the site of the eruption.
Typical target lesions may not be apparent until several
days after the onset, when lesions of various clinical
morphology usually are present, hence the name erythema
“multiforme” [15,17]. Diagnosis of erythema multiforme is
clinical, and requires careful differential diagnosis because
its presentation is associated to an extremely wide series of
diseases, such as drug eruption, lupus erythematosus,
Stevens-Johnson syndrome, toxic epidermal necrolysis, ur-
ticaria, viral exanthems and vasculitis [15].
In the case we described there was no development of
coronary abnormalities, but electrocardiography showed
completely reversible abnormalities in ventricular repo-
larization. This finding is compatible with Kawasaki dis-
ease, where ECG may show arrhythmia, prolonged PR
interval, or non specific ST and T wave changes [1]. Fi-
nally, we demonstrated previous streptococcus pyogenes
infection and we hypothesized it as a trigger for Kawasaki
disease development, as previously described [14,18]. An
infectious trigger of Kawasaki disease has been suspected
by the epidemiologic features, such as age of affected chil-
dren, seasonality of cases, and occurrence of community
outbreaks and epidemics [1]; however, no known infec-
tious agent has been consistently found [19]. As strepto-
cocci are infectious agents associated even with erythema
multiforme [20], therefore it is possible to speculate that,
in our case, streptococcus pyogenes infection may have
been a common trigger underlying both conditions, Kawa-
saki disease being the end result of an extensive immune
activation in a predisposed host.
After the publication of American Heart Association
algorithm in 2004, the diagnosis of incomplete Kawasaki
disease is increased, primarily due to a systematic per-
formance of laboratoristic evaluation [21]. Indeed, even
if the laboratory findings of incomplete cases appear to
overlap to those of classic ones, they may prove useful in
heightening or reducing the suspicion of incomplete
Kawasaki disease [1]. Nevertheless, the description of
Kawasaki disease cases, characterized by unusual presen-
tation, in terms of clinical signs, is extremely useful to
plan the diagnosis of a so intriguing disease.
Conclusions
The paper indicates erythema multiforme as a possible
early cutaneous manifestation of Kawasaki disease, par-
ticularly in the case of the incomplete form. This acqui-
sition is strongly important in the pediatric practice to
avoid delaying in diagnosis and to promptly start ad-
equate treatment.
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